AGI AGI

TIDMAGI

RNS Number : 2864V

AGI Therapeutics plc

10 January 2012

 
                                FORM 8.3 
 
                          IRISH TAKEOVER PANEL 
 
             DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER 
           PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) 
 
             DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT 
                   SECURITIES REPRESENTING 1% OR MORE 
 
                           1. KEY INFORMATION 
================================================================ 
Name of person dealing        Aiden Maguire 
 (Note 1) 
============================  ================================== 
Company dealt in              AGI Therapeutics plc 
============================  ================================== 
Class of relevant security    Ordinary Shares of EUR0.01 
 to which the dealings         each 
 being disclosed relate 
 (Note 2) 
============================  ================================== 
Date of dealing               9 January 2012 
============================  ================================== 
 
 
  2. INTERESTS AND SHORT POSITIONS 
 
  (a) Interests and short positions (following 
  dealing) in the class of relevant security dealt 
  in (Note 3) 
================================================================ 
                                         Long              Short 
============================  ===============  ================= 
                              Number (%)        Number (%) 
============================  ===============  ================= 
(1) Relevant securities       1,038,999 1.5%   0 0 
============================  ===============  ================= 
(2) Derivatives (other 
 than options)                0 0              0 0 
============================  ===============  ================= 
(3) Options and agreements 
 to purchase/sell             0 0              0 0 
============================  ===============  ================= 
Total                         1,038,999 1.5%   0 0 
============================  ===============  ================= 
 (b) Interests and short positions in relevant 
  securities of the company, other than the class 
  dealt in (Note 3) 
================================================================ 
Class of relevant security:              Long              Short 
============================  ===============  ================= 
                              Number (%)        Number (%) 
============================  ===============  ================= 
 
 (1) Relevant securities      0 0              0 0 
============================  ===============  ================= 
 
 (2) Derivatives (other 
 than options)                0 0              0 0 
============================  ===============  ================= 
 
 (3) Options and agreements 
 to purchase/sell             0 0              0 0 
============================  ===============  ================= 
 
 Total                        0 0              0 0 
============================  ===============  ================= 
 
 
 
 
                                                 1 February 2009 
 
 
3. DEALINGS (Note 4) 
 
 (a) Purchases and sales 
=================================================================================================================== 
 
 Purchase/sale                           Number of relevant securities                     Price per unit 
                                                                                           (Note 5) 
===============================  ===================================================  ============================= 
Purchase                         463,999                                              EUR0.06 
===============================  ===================================================  ============================= 
 
 
 (b) Derivatives transactions (other than options 
 transactions) 
=================================================================================================================== 
Product 
 name, e.g.            Nature of transaction             Number of relevant                         Price per 
 CFD                                                     securities                                 unit 
                       (Note 6) 
                                                         (Note 7)                                   (Note 5) 
====================  ================================  ========================================  ================= 
N/A 
====================  ================================  ========================================  ================= 
 
 
 (c) Options transactions in respect of existing 
 relevant securities 
 
 (i) Writing, selling, purchasing or varying 
=================================================================================================================== 
Product        Writing,                   Number of          Exercise    Type,              Expiry    Option 
 name, e.g.     selling,                   securities         price       e.g. American,     date     money 
 call option    purchasing,                to which                       European                    paid/received 
                varying                    the option                     etc.                        per unit 
                etc.                       relates (Note                                              (Note 
                                           7)                                                         5) 
=============  =========================  ================  ===========  =================  ========  ============= 
N/A 
===============================  =======  ================  ===========  =================  ========  ============= 
 
 
 
 (ii) Exercising 
=================================================================================================================== 
Product name,                           Number of securities                              Exercise price 
 e.g. call option                                                                          per unit (Note 
                                                                                           5) 
===============================  ===================================================  ============================= 
N/A 
===============================  ===================================================  ============================= 
 
 
 
 (d) Other dealings (including transactions in 
 respect of new securities) (Note 4) 
=================================================================================================================== 
Nature of transaction                   Details                                           Price per unit 
 (Note 8)                                                                                  (if applicable) 
                                                                                           (Note 5) 
===============================  ===================================================  ============================= 
N/A 
===============================  ===================================================  ============================= 
 
 
 
 
 
 
                                                                                                    1 February 2009 
 
 
 
4. OTHER INFORMATION 
 
 Agreements, arrangements or understandings relating 
 to options or derivatives 
======================================================= 
Full details of any agreement, arrangement or 
 understanding between the person disclosing and 
 any other person relating to the voting rights 
 of any relevant securities under any option referred 
 to on this form or relating to the voting rights 
 or future acquisition or disposal of any relevant 
 securities to which any derivative referred to 
 on this form is referenced. If none, this should 
 be stated. 
======================================================= 
N/A 
======================================================= 
 
 
 
 Is a Supplemental Form 8 attached? (Note 9) YES/NO 
======================================================= 
Date of disclosure                   9 January 2012 
===================================  ================== 
Contact name                         Aiden Maguire 
===================================  ================== 
Telephone number 
===================================  ================== 
If a connected EFM, name             N/A 
 of offeree/offeror with 
 which connected 
===================================  ================== 
If a connected EFM, state            N/A 
 nature of connection (Note 
 10) 
===================================  ================== 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                        1 February 2009 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETURVRRUWAAAAR

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025